Chemotherapy

AuraZyme Presents Progress Report On Cancer Drug Delivery System

Published in Gene Therapy Weekly, October 18th, 2001

AuraZyme Pharmaceuticals Inc., a subsidiary of CryoLife Inc. (CRY), presented results of animal studies on its A-Z-CINN Linker for targeted delivery of anticancer chemotherapy drugs, at the recent First International Congress on Monoclonal Antibodies held in Banff, Alberta, Canada.

The multidiscipline congress was organized to provide scientists or researchers from leading biotechnology companies and university laboratories with a forum on new developments using monoclonal antibodies in the treatment of both solid tumors and hematological malignances.

Kirby S. Black, PhD, senior vice president of research and development at CryoLife and head of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2001-10-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry